{"id":"W2410968598","doi":"10.1358/dot.2004.40.7.850479","title":"Recent developments in lipid-lowering therapy - Highlights from theAtorvastatin Landmark Program: Global Investigators Meeting III","year":2004,"lang":"en","type":"article","venue":"Drugs of today","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Medicine; Landmark; Guideline; Clinical trial; Clinical Practice; Modalities; Medical physics; Family medicine; Pharmacology; Pathology; Artificial intelligence; Computer science","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005899433,0.0002034978,0.0005009715,0.00007067883,0.0000590458,0.00001717209,0.0001303353,0.0001093375,0.00002824046],"category_scores_gemma":[0.00006296566,0.0001594272,0.0001330639,0.0003811787,0.00005397591,0.00007377139,0.00005209331,0.0001553965,0.000009287612],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000326578,"about_ca_system_score_gemma":0.0004794431,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004346543,"about_ca_topic_score_gemma":0.000194599,"domain_scores_codex":[0.9981783,0.00006203908,0.0004896227,0.0003366098,0.0005655311,0.0003679064],"domain_scores_gemma":[0.9991878,0.00002245928,0.0001271698,0.0003537828,0.00008358842,0.0002251907],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.000485947,0.0007085108,0.06079326,0.000143195,0.0004598029,0.00008161079,0.004769878,0.00005975738,0.001808316,0.0004221084,0.000205142,0.9300625],"study_design_scores_gemma":[0.03377271,0.0008585689,0.4349658,0.004241677,0.0001384829,0.00003458997,0.001838496,0.00002372362,0.2010129,0.002148598,0.31989,0.001074449],"study_design_candidate":"design_other","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917538,0.002119636,0.00001858218,0.00108122,0.0002776389,0.0008894343,0.00001029427,0.0000881149,0.003761243],"genre_scores_gemma":[0.9877288,0.00200524,0.009465068,0.0004193414,0.0002095999,0.00008032114,0.00004805972,0.00002578419,0.00001782382],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.928988,"threshold_uncertainty_score":0.6570701,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01544992483414326,"score_gpt":0.2747528325590962,"score_spread":0.2593029077249529,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}